The gut microbiome interacts with the loss of female sex hormones to exacerbate metabolic disease, including weight gain, fat in the liver and the expression of genes linked with inflammation, researchers found in a new rodent study. The findings, published in the journal...

Dr. Kemper is Professor Emeritus of Molecular & Integrative Physiology. Her lab focuses on metabolic signaling and epigenomic control of metabolism and energy balance.

CHAMPAIGN, Ill. — Less than 20% of diagnosed breast cancers are designated “triple-negative,” meaning that the affected tissues lack three types of receptors often found in other breast cancer types, but TNBCs are often aggressive with ...

Urbana, Ill. – A new study by Cancer Center at Illinois Education Program Leader, Zeynep Madak-Erdogan and her team, have found a new mechanism of endocrine resistance in breast cancers metastasized to the liver.

A graduate student in the School of Molecular & Cellular Biology competed in the Illinois Graduate College's Research Live! Showcase at the Krannert Center for Performing Arts.

Dr. Nelson’s lab focuses on determining how different hormones and metabolite factors impact breast and ovarian cancer progression.

Professor Lori Raetzman joined the University of Illinois at Urbana-Champaign in 2005. Since joining, the Raetzman group has produced highly impactful work regarding the development and function of both the pituitary gland and the hypothalamus. Over the past 14 years, students from the Raetzman lab...